Paragon 28 Inc FNA
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if FNA is a good fit for your portfolio.
News
-
Paragon 28 Reports First Quarter 2024 Financial Results and Reaffirms 2024 Net Revenue Guidance
-
Paragon 28 to Present at the Bank of America Securities 2024 Healthcare Conference
-
Paragon 28 Announces CFO Transition, Provides Preliminary Unaudited Net Revenue for First Quarter 2024, and Reaffirms Net Revenue Guidance for Fiscal Year 2024
-
Paragon 28 Adds to Suite of Novel Syndesmosis Repair Solutions with Launch of Grappler® R3INFORCE™ Extraosseous Repair System
-
Paragon 28 Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Net Revenue Guidance
Trading Information
- Previous Close Price
- $8.10
- Day Range
- $7.95–8.18
- 52-Week Range
- $7.60–19.00
- Bid/Ask
- $7.54 / $8.30
- Market Cap
- $661.12 Mil
- Volume/Avg
- 537,272 / 583,211
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 2.92
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Paragon 28 Inc is a medical devices company that develops, distributes, and sells medical devices in the foot and ankle segment of the orthopedic implant marketplace. Its products include plates and plating systems, screws, staples, and nails aimed to address all major foot and ankle procedures including ankle, Charcot, fracture fixation, hallux valgus, hammertoe, and flat foot. The company's suite of surgical solutions comprises nearly 80 product systems to help fit the specific needs of each patient and procedure. Geographically the company generates the majority of its revenue from the United States.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Core
- Total Number of Employees
- 574
- Website
- https://www.paragon28.com
Comparables
Valuation
Metric
|
FNA
|
ZIMV
|
MMSI
|
---|---|---|---|
Price/Earnings (Normalized) | — | 19.26 | 26.20 |
Price/Book Value | 4.02 | 1.19 | 3.85 |
Price/Sales | 2.92 | 0.83 | 3.75 |
Price/Cash Flow | — | 18.90 | 21.07 |
Price/Earnings
FNA
ZIMV
MMSI
Financial Strength
Metric
|
FNA
|
ZIMV
|
MMSI
|
---|---|---|---|
Quick Ratio | 1.71 | 0.84 | 4.22 |
Current Ratio | 3.57 | 2.78 | 6.03 |
Interest Coverage | −7.13 | −1.51 | 6.17 |
Quick Ratio
FNA
ZIMV
MMSI
Profitability
Metric
|
FNA
|
ZIMV
|
MMSI
|
---|---|---|---|
Return on Assets (Normalized) | −12.68% | 14.12% | 9.17% |
Return on Equity (Normalized) | −21.35% | 31.63% | 15.14% |
Return on Invested Capital (Normalized) | −13.54% | 18.79% | 10.93% |
Return on Assets
FNA
ZIMV
MMSI
Medical Devices Industry Comparables
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
---|---|---|---|---|---|
ABT
| Abbott Laboratories | Rsdbsrh | Lyxhbl | $182.4 Bil | |
SYK
| Stryker Corp | Ctltbjyhsp | Ggjmp | $126.5 Bil | |
MDT
| Medtronic PLC | Cmpfkjsv | Cwkvrz | $111.9 Bil | |
BSX
| Boston Scientific Corp | Vdspgqxc | Lksjkn | $108.0 Bil | |
EW
| Edwards Lifesciences Corp | Pfvpgcrmmf | Msdyrth | $54.3 Bil | |
DXCM
| DexCom Inc | Tcdsfmvnv | Whnlk | $52.2 Bil | |
PHG
| Koninklijke Philips NV ADR | Zrtxzqjl | Vykyvz | $25.6 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Wndqdhccr | Rksf | $24.9 Bil | |
ALGN
| Align Technology Inc | Vwqkgkp | Mbdgjh | $20.6 Bil | |
SNN
| Smith & Nephew PLC ADR | Xjlvjhhxr | Tjnjfp | $11.4 Bil |